Effects of Vaccine Program against Pandemic Influenza A(H1N1) Virus, United States, 2009–2010
Open Access
- 1 March 2013
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 19 (3), 439-448
- https://doi.org/10.3201/eid1903.120394
Abstract
Vaccination likely prevented 700,000–1,500,000 clinical cases, 4,000–10,000 hospitalizations, and 200–500 deaths.Keywords
This publication has 27 references indexed in Scilit:
- Post-Pandemic Seroprevalence of Pandemic Influenza A (H1N1) 2009 Infection (Swine Flu) among Children <18 Years in GermanyPLOS ONE, 2011
- H1N1 Hemagglutinin-Inhibition Seroprevalence in Emergency Department Health Care Workers After the First Wave of the 2009 Influenza PandemicPediatric Emergency Care, 2011
- Serologically Confirmed Household Transmission of 2009 Pandemic Influenza A (H1N1) Virus During the First Pandemic Wave--New York City, April-May 2009Clinical Infectious Diseases, 2011
- Sensitivity and Specificity of Serologic Assays for Detection of Human Infection with 2009 Pandemic H1N1 Virus in U.S. PopulationsJournal of Clinical Microbiology, 2011
- Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control StudyPLoS Medicine, 2011
- Safety and Effectiveness of a 2009 H1N1 Vaccine in BeijingThe New England Journal of Medicine, 2010
- Estimates of the Prevalence of Pandemic (H1N1) 2009, United States, April–July 2009Emerging Infectious Diseases, 2009
- Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009The New England Journal of Medicine, 2009
- Comparative Efficacy of Inactivated and Live Attenuated Influenza VaccinesThe New England Journal of Medicine, 2009
- Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge StudiesAmerican Journal of Epidemiology, 2008